7 November 2007
CRT Appoints Director of Discovery
16 October 2007
Breast Cancer diagnostic Markers Licensed by Perlegen in Agreement with University of Cambridge And Cancer Research Technology
3 September 2007
Vernalis receives milestone payment in Hsp90 inhibitor collaboration
22 August 2007
Antisoma’s ASA404 lung cancer trial will report positive survival data
31 July 2008
CRT Licenses Colorectal Cancer Risk Technology
20 June 2007
Cancer Research Technology Licenses Novel Toll-like Receptor Agents to Innate Pharma
2 May 2007
Cancer Research Technology Licenses Therapeutic Antibodies to Peptech
2 April 2007
New CEO to Spearhead Laboratory Expansion at Cancer Research Technology
1 March 2007
Fox Chase Cancer Center and Cancer Research Technology Inc. Initiate Drug Discovery Collaboration
6 February 2007
Progression of Checkpoint Kinase 1 Drug Discovery Programme
11 January 2007
Cancer Research Technology Announce Milestone following Initiation of Stimuvax® Phase 3 Trial in Non Small Cell Lung Cancer
|
